Another consideration is drug interactions—CYP2D6 inhibitors (like paroxetine) can phenocopy a poor metabolizer, causing drug buildup [65]; such interactions in an OSA patient on opioids could precipitate unexpected respiratory depression. Here, CYP2D6 is linked to obstructive sleep apnea syndrome.